Calls Now Open

2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs

You've just added:


William Wulftange

William Wulftange

Case Western Reserve University

Disease Area



A Novel Human Tissue-on-a-Chip Approach for Predicting the Safety of CAR-T Cell Therapies

Scholar Profile

2022 Harrington-MSTP Scholar

Full profile coming soon.

Revolutionizing CAR T-Cell Therapy: Making It Safe

Dive into the world of revolutionary cancer treatment with William Wulftange, a 2022 Harrington-MSTP Scholar from Case Western Reserve University. CAR T-cell therapy is changing the game in the fight against leukemia, with some patients achieving total cancer-free status for a decade. However, these therapies come with severe side effects that can be life-threatening. He's designing cutting-edge assays to test the biomechanical properties of CAR T-cells. By doing so, he aims to determine whether a specific therapy is both safe and effective for the patient receiving it.

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.